Inexpensive assay detects fake malaria drugs
17 July, 2014Chemists from Oregon State University (OSU) have created a simple, inexpensive assay which can tell whether or not one of the primary drugs being used to treat malaria is genuine.
Enzo Life Sciences cortisol ELISA kit
30 June, 2014The cortisol ELISA kit from Enzo Life Sciences can be used with a large variety of sample types and produces highly reproducible results for stress, autoimmune disease and cancer research.
Qiagen artus CMV RGQ MDx Kit
19 June, 2014Qiagen's artus CMV RGQ MDx Kit for human cytomegalovirus (CMV) has been approved by the US Food and Drug Administration (FDA) under a full premarket approval (PMA). The PCR-based assay is optimised for low- to mid-throughput testing of CMV.
Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs
16 April, 2014The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNVs) in patients referred for chromosomal testing. It is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
Biomedica NT-proBNP ELISA for determination of heart failure
31 January, 2014NT-proBNP brain natriuretic peptide, a member of the cardiac natriuretic hormones (CNHs) family, is secreted by the hemodynamically stressed heart, mainly in response to myocardial stretch induced by volume overload. The NT-proBNP ELISA from Biomedica provides reproducible results with an easy-to-use, convenient 96-well protocol (5 standards, 1 control).
Qiagen submits C. difficile assay to FDA
30 January, 2014Qiagen plans to roll out a portfolio of assays for the QIAsymphony platform to aid in the diagnosis of healthcare-associated infections (HAIs). The company's first new test, the artus C. difficile QS-RGQ MDx Kit, has been submitted to the US Food and Drug Administration (FDA).
Enzo Life Sciences trefoil factor 1 (human) ELISA kit
30 January, 2014Enzo Life Sciences has introduced an ELISA kit to quantify trefoil factor 1 in a wide variety of sample types - including bronchoalveolar lavage fluid, plasma or serum - for immunity and inflammation research.
Gradientech CellDirector 2D chemotaxis assays
20 November, 2013CellDirector cell-based assays are microscale tools for live imaging and analysis of cell migration and behaviour in response to stable chemotactic concentration gradients. The CellDirector 2D assay can be used to study the chemotactic effect of any soluble substance on any type of adherent cell.
Enzo Life Sciences Leading Light Sclerostin-LRP Screening System
14 November, 2013Enzo Life Sciences has expanded its portfolio of Wnt Pathway assays with the Leading Light Sclerostin-LRP Screening System. The simple, rapid biochemical binding assay format does not require cell lines or transfection reagents.
Cosmo Bio Rat/Mouse SP-D ELISA Kit
12 November, 2013Cosmo Bio has launched the rat/mouse surfactant protein D (SP-D) sandwich ELISA, which measures the concentration of rat/mouse SP-D using two monoclonal antibodies against rat SP-D.
BellBrook Labs Transcreener HTS enzyme assays
27 September, 2013Transcreener HTS assays are a universal, high-throughput screening platform for thousands of nucleotide-dependent enzymes, such as kinases, ATPases and GTPases.
3M Food Safety 3M Molecular Detection Assay Listeria monocytogenes
30 August, 20133M Food Safety has announced the launch of its 3M Molecular Detection Assay Listeria monocytogenes. The system provides pure and simple testing for dangerous pathogens in a variety of food matrices.
GE Healthcare Biacore 4000 molecular interaction analysis system
07 August, 2013The Biacore 4000 offers a complete solution for large-scale, label-free molecular interaction analysis, delivering high throughput without compromising on data quality.
Cosmo Bio D-Serine Colorimetric Assay Kit
02 August, 2013The D-Serine Colorimetric Assay Kit from Cosmo Bio employs the D-form specific enzyme D-serine dehydratase from Saccharomyces cerevisiae (DsdSC), enabling the quantitation of D-serine by spectrophotometric measurement.
FDA permits marketing of TB bacteria and antibiotic-resistance test
26 July, 2013The US Food and Drug Administration (FDA) has authorised the marketing of the Xpert MTB/RIF assay, manufactured by Cepheid. This is the first FDA-reviewed test that can rapidly detect the bacteria that cause tuberculosis (TB) and determine if the bacteria contain genetic markers that make them resistant to rifampin, an important antibiotic for the treatment of TB.
